Highlights from the 3rd Annual Seminar Series on Solid Tumors & Precision Medicine: An Expert Q&A

Highlights from the 3rd Annual Seminar Series on Solid Tumors & Precision Medicine: An Expert Q&A is organized by Prime Education LLC.

Dates:
Release Date: November 29, 2019
Expiration Date: November 29, 2020

Accreditation:
• 1.5 CME/CE for Physicians (ACCME)
• 1.5 CME/CE for Physician Assistants (AAPA)
• 1.5 CME/CE for Nurse Practitioners (AANP)
• 1.5 CPE for Pharmacists (ACPE + NABP)
• 1.5 CNE for Nurses (ANCC)
• 1.5 CE for Case Managers (CCM, pre-approved)

Activity Overview:
Don't miss this expert Q&A brimming with practice-changing takeaways from a recent seminar series. Hear Drs Michael Kelley, Daniel Petrylak, and Edith Mitchell answer critical questions on how to utilize molecular testing and targeted therapies and immunotherapies to manage patients with solid tumors and improve outcomes in federal, public, and government health care settings.

Learning Objectives:
• Discuss the role of molecular, predictive, and prognostic factors in guiding treatment decisions for patients with prostate, lung, and colorectal cancers
• Assess the efficacy and safety of targeted therapies and immunotherapies to inform treatment decisions
• Apply evidence-based and expert consensus for the diagnosis, treatment, and management of patients with prostate, lung, and colorectal cancers

Additional details will be posted as soon as information is available.